Invesco MF launches India Pharma and Healthcare NFO
The fund aims to tap India’s evolving healthcare ecosystem, which is being shaped by favourable demographics, expanding healthcare access and rising insurance penetration
Invesco Mutual Fund has introduced a new India Pharma and Healthcare NFO, intending to invest across various sectors of the healthcare industry. The fund aims to capitalize on India's growing healthcare ecosystem, which is being influenced by favorable demographics, expanded healthcare access, and increasing insurance penetration.
India holds a unique position in the global healthcare landscape due to its large population, skilled workforce, manufacturing prowess, and expanding innovation capabilities. The fund will be overseen by Aditya Khemani, Head of Equity and Fund Manager at Invesco MF, and will be benchmarked against the BSE Healthcare TRI. Khemani emphasized that India is experiencing rising healthcare consumption due to favorable demographics and affordability improvements, while also reinforcing its status as a global pharmaceutical and healthcare innovation hub. The New Fund Offer (NFO) for this investment vehicle will accept subscriptions until September 1.
Written by urgent.news from Hindu BusinessLine's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
